TMEM216

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, TMEM216 mutation is significantly associated with the immune_cell of many other genes, with 3 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible TMEM216-associated genes across cancer lineages are Epithelial cells, Mesangial cells, and Myocytes. Each is linked with TMEM216 in more than 1 cancer types. Because this analysis shows association rather than direction, both TMEM216-to-partner and partner-to-TMEM216 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (TMEM216→partner) and Y-score (partner→TMEM216) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECEpithelial cells →-0.136-2.989<.001.03531
UCECMesangial cells →-0.059-3.159.005.02011
UCECMyocytes →+0.048+3.212.006.01011
Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Exploration